HomeIMRSQ • OTCMKTS
IMRIS Ord Shs
$0.00
May 6, 12:19:19 AM GMT-4 · USD · OTCMKTS · Disclaimer
StockUS listed securityCA headquartered
Previous close
$0.00
Avg Volume
372.00
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
(USD)2014Y/Y change
Revenue
28.89M
Operating expense
33.07M
Net income
-30.39M
Net profit margin
-105.18
Earnings per share
-0.5830.12%
EBITDA
-20.30M
Effective tax rate
-0.80%
Total assets
Total liabilities
(USD)2014Y/Y change
Cash and short-term investments
5.00M
Total assets
65.48M
Total liabilities
53.69M
Total equity
11.79M
Shares outstanding
62.59M
Price to book
0.00
Return on assets
-19.15%
Return on capital
-31.61%
Net change in cash
(USD)2014Y/Y change
Net income
-30.39M
Cash from operations
-10.91M
Cash from investing
4.49M
Cash from financing
3.50M
Net change in cash
-1.38M
Free cash flow
4.58M
About
IMRIS, founded in 2005, is a global provider of intraoperative imaging solutions. The company's flagship product is the IMRIS Surgical Theatre. A hybrid operating theatre with intraoperative imaging capabilities, The IMRIS Surgical Theatre incorporates design and technology provided by IMRIS, including the moveable intraoperative MRI, as well as technology from 3rd-party medical device companies. IMRIS designs, creates and supports the IMRIS Surgical Theatre, which the company's marketing materials describe as "the world's most advanced hybrid operating theatre." Wikipedia
Founded
2005
Website
Employees
121
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu